Abstract: This invention relates to mouse and human EGFH2, and to variants thereof and to polynucleotides encoding EGFH2. This invention also relates to therapeutic agents related to the polynucleotides and proteins.
Type:
Grant
Filed:
August 15, 2000
Date of Patent:
November 30, 2004
Assignee:
Chiron Corporation
Inventors:
W. Michael Kavanaugh, Hui Cen, Pauline Lee